Charting a new course for pancreatic disease Learn more
The Brenden-Colson Center for Pancreatic Care is a patient centric hub for clinical and research programs that focus on three main areas essential for alleviating suffering from pancreatic diseases: Early Detection, Advanced Therapy, and Quality of Life. The heart of the program is a close collaboration among five program leaders in a "center-without-walls" that connects clinical activities to laboratory research.
The clinical program is led by Co-Director Brett C. Sheppard, M.D., who links his surgical care and research activities with the programs of three stellar Knight Cancer Institute researchers, Brenden-Colson Center Co-Director Rosalie C. Sears, Ph.D., Lisa M. Coussens, Ph.D., and Joe W. Gray, Ph.D, and with the clinical program of oncologist Charles Lopez, M.D, Ph.D. Each researcher helps to direct team projects that advance the search for new detection methods, move promising new stand-alone and combination therapies into the clinical trials pipeline and search for novel therapies to enhance quality of life.
From this foundation, we continue to expand our network of collaborators, partners, and patients to enable us to make the leaps necessary to improve patient care.
Use the navigational bars above to find out more information about the Brenden-Colson Center activities or view a snapshot of the Brenden-Colson Center here.